Using lysosomal and proteasomal degradation inhibitors, we observed that NFATc1 induces lysosomal degradation of Orai3 in both invasive and metastatic pancreatic cancer cells (Fig. 4A–D). This evidence concerns the gene NFATC1 and familial pancreatic carcinoma.